RU94040393A - Синтетические пептиды для вакцины против краснухи - Google Patents
Синтетические пептиды для вакцины против краснухиInfo
- Publication number
- RU94040393A RU94040393A RU94040393/13A RU94040393A RU94040393A RU 94040393 A RU94040393 A RU 94040393A RU 94040393/13 A RU94040393/13 A RU 94040393/13A RU 94040393 A RU94040393 A RU 94040393A RU 94040393 A RU94040393 A RU 94040393A
- Authority
- RU
- Russia
- Prior art keywords
- protein
- rubella
- synthetic peptides
- vaccine against
- german measles
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 5
- 201000005404 rubella Diseases 0.000 title claims abstract 3
- 229960005486 vaccine Drugs 0.000 title 1
- 241000710799 Rubella virus Species 0.000 claims abstract 4
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract 2
- 101710117545 C protein Proteins 0.000 claims abstract 2
- 101710125507 Integrase/recombinase Proteins 0.000 claims abstract 2
- 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 claims abstract 2
- 101710172711 Structural protein Proteins 0.000 claims abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 230000000890 antigenic effect Effects 0.000 claims abstract 2
- 125000003473 lipid group Chemical class 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 229960003131 rubella vaccine Drugs 0.000 claims abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Синтетические пептиды, содержащие аминокислотную последовательность, соответствующую, по крайней мере, одной антигенной детерминанте, по крайней мере, одного протеина, обычно структурного протеина, особенно Е1, Е2 или С протеина, вируса краснухи (RV) используют как они есть в гибридном или химерическом тандеме в Т-В форме, в модифицированной липидной форме, связанные с молекулой носителя и/или полимеризованные до получения молекулярных агрегатов, в вакцинах против вируса краснухи. Аналогичные пептиды, которые являются детерминантами Т-клеток человека, используют для лечения связанных с краснухой автоиммунных заболеваний.
Claims (1)
- Синтетические пептиды, содержащие аминокислотную последовательность, соответствующую, по крайней мере, одной антигенной детерминанте, по крайней мере, одного протеина, обычно структурного протеина, особенно Е1, Е2 или С протеина, вируса краснухи (RV) используют как они есть в гибридном или химерическом тандеме в Т-В форме, в модифицированной липидной форме, связанные с молекулой носителя и/или полимеризованные до получения молекулярных агрегатов, в вакцинах против вируса краснухи. Аналогичные пептиды, которые являются детерминантами Т-клеток человека, используют для лечения связанных с краснухой автоиммунных заболеваний.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9201139.4 | 1992-01-20 | ||
| GB929201139A GB9201139D0 (en) | 1992-01-20 | 1992-01-20 | Synthetic peptides for a rubella vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU94040393A true RU94040393A (ru) | 1996-11-10 |
Family
ID=10708876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU94040393/13A RU94040393A (ru) | 1992-01-20 | 1993-01-20 | Синтетические пептиды для вакцины против краснухи |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6037448A (ru) |
| EP (1) | EP0624198A1 (ru) |
| JP (1) | JPH07503133A (ru) |
| AU (1) | AU662954B2 (ru) |
| CA (1) | CA2128407C (ru) |
| FI (1) | FI943418L (ru) |
| GB (1) | GB9201139D0 (ru) |
| NO (1) | NO942707L (ru) |
| RU (1) | RU94040393A (ru) |
| WO (1) | WO1993014206A2 (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2737638C2 (ru) * | 2013-12-03 | 2020-12-01 | Вирометикс Аг | ПРОЛИН-БОГАТЫЕ ПЕПТИДЫ, ЗАЩИЩАЮЩИЕ ОТ S.pneumoniae |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5427792A (en) * | 1989-08-23 | 1995-06-27 | Biochem Immunosystems, Inc. | Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
| WO1997026538A1 (en) * | 1996-01-19 | 1997-07-24 | Virginia Mason Research Center | Allele-specific peptide epitope strategy for vaccine development |
| CA2238660A1 (en) * | 1998-05-22 | 1999-11-22 | Janet Chantler | Gene sequences of rubella virus associated with attenuation |
| SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| AU2002326070A1 (en) * | 2001-07-02 | 2003-01-21 | Elan Corporation, Plc | Peyers's patch and/or m-celle targeting ligands |
| KR101580660B1 (ko) | 2007-08-02 | 2015-12-28 | 바이오앤드백스 파마슈티칼즈, 리미티드. | 다중체 다중-에피토프 인플루엔자 백신 |
| CN103517713A (zh) | 2011-02-22 | 2014-01-15 | 彼昂德瓦克斯医药有限公司 | 在改善的季节性和大流行性流感疫苗中的多聚体多表位多肽 |
| CN107098980A (zh) * | 2017-06-28 | 2017-08-29 | 潍坊汉唐生物工程有限公司 | 一种检测风疹病毒抗体的融合蛋白及其制备方法 |
| CN116376977B (zh) * | 2023-03-23 | 2024-11-19 | 北京巴瑞医疗器械有限公司 | 风疹病毒重组病毒样颗粒表达载体及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2206587A (en) * | 1987-07-08 | 1989-01-11 | London Biotechnology Ltd | Rubella e1 glycoprotein antigens |
| US5164481A (en) * | 1989-08-23 | 1992-11-17 | Iaf Biochem International Inc. | Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
-
1992
- 1992-01-20 GB GB929201139A patent/GB9201139D0/en active Pending
-
1993
- 1993-01-20 RU RU94040393/13A patent/RU94040393A/ru unknown
- 1993-01-20 JP JP5512042A patent/JPH07503133A/ja active Pending
- 1993-01-20 CA CA002128407A patent/CA2128407C/en not_active Expired - Lifetime
- 1993-01-20 US US08/256,747 patent/US6037448A/en not_active Expired - Lifetime
- 1993-01-20 AU AU33413/93A patent/AU662954B2/en not_active Ceased
- 1993-01-20 WO PCT/CA1993/000014 patent/WO1993014206A2/en not_active Application Discontinuation
- 1993-01-20 EP EP93901999A patent/EP0624198A1/en not_active Withdrawn
-
1994
- 1994-07-19 FI FI943418A patent/FI943418L/fi not_active Application Discontinuation
- 1994-07-19 NO NO942707A patent/NO942707L/no unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2737638C2 (ru) * | 2013-12-03 | 2020-12-01 | Вирометикс Аг | ПРОЛИН-БОГАТЫЕ ПЕПТИДЫ, ЗАЩИЩАЮЩИЕ ОТ S.pneumoniae |
Also Published As
| Publication number | Publication date |
|---|---|
| FI943418A0 (fi) | 1994-07-19 |
| JPH07503133A (ja) | 1995-04-06 |
| US6037448A (en) | 2000-03-14 |
| CA2128407A1 (en) | 1993-07-22 |
| FI943418L (fi) | 1994-09-15 |
| WO1993014206A2 (en) | 1993-07-22 |
| AU3341393A (en) | 1993-08-03 |
| NO942707D0 (no) | 1994-07-19 |
| EP0624198A1 (en) | 1994-11-17 |
| WO1993014206A3 (en) | 1993-10-28 |
| NO942707L (no) | 1994-09-20 |
| GB9201139D0 (en) | 1992-03-11 |
| CA2128407C (en) | 2002-04-09 |
| AU662954B2 (en) | 1995-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94040386A (ru) | Синтетический пептид, синтетический липопептид, иммуногенный коньюгат, вектор, диагностический реагент, метод определения инфекций, антитета, способ получения олигомера, синтетическая вакцина против haemophilus influenzae, защищенный полисахарид | |
| AU591054B2 (en) | Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics | |
| GR1000083B (el) | Μυκητοβακτηριακα προιοντα εξ ανασυνθεσεως και πεπτιδια. | |
| CA2164818A1 (en) | Tandem synthetic hiv-1 peptides | |
| DE69739035D1 (de) | Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen | |
| DE69934967D1 (de) | Verfahren zur verminderung der immunogenität von proteinen | |
| ES2112838T3 (es) | Peptidos receptores de celulas t como agentes terapeuticos para enfermedades autoinmunitarias y malignas. | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
| RU94040393A (ru) | Синтетические пептиды для вакцины против краснухи | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| ATE134195T1 (de) | Peptidfragmente von hiv | |
| CA2132742A1 (en) | Synthetic Peptides and Vaccines Against Parvovirus | |
| ATE221786T1 (de) | Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus | |
| ATE269904T1 (de) | Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien | |
| IE870507L (en) | Bovine virus diarrhea and hog cholera vaccines | |
| AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
| Alekseeva et al. | Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues. | |
| ES2065254A1 (es) | Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. | |
| ES1027961U (es) | Soporte publicitario para carritos. |